C12N 2795/00043
Viral genome or elements thereof as genetic vector
Official title: viral genome or elements thereof as genetic vector
C12N2795/00043 (Viral genome or elements thereof as genetic vector) appears on 55 US grants and 87 published applications in this corpus.
Search patents in C12N- Granted patents
- 55
- Published applications
- 87
- Assignees
- 46
- Inventors
- 137
- Latest grant
- 1 Jul 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2001 | 2 | 0 |
| 2002 | 0 | 0 |
| 2003 | 1 | 2 |
| 2004 | 0 | 2 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 1 | 1 |
| 2009 | 1 | 1 |
| 2010 | 0 | 4 |
| 2011 | 0 | 6 |
| 2012 | 1 | 2 |
| 2013 | 1 | 1 |
| 2014 | 1 | 3 |
| 2015 | 6 | 0 |
| 2016 | 3 | 5 |
| 2017 | 2 | 6 |
| 2018 | 3 | 2 |
| 2019 | 5 | 8 |
| 2020 | 3 | 3 |
| 2021 | 2 | 5 |
| 2022 | 4 | 11 |
| 2023 | 9 | 11 |
| 2024 | 7 | 7 |
| 2025 | 3 | 2 |
| 2026 | 0 | 5 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Targeted genome modification using circular single-stranded DNA1 Jul 2025US 12,344,858 B2Full Circles Therapeutics, Inc.
- Phagemid vector17 Jun 2025US 12,331,308 B2Imperial College Innovations Limited
- Bacteriophage-based artificial viruses for human genome remodeling4 Mar 2025US 12,241,080 B2The Catholic University of America
- Immunogenic composition3 Sep 2024US 12,076,352 B2Glaxosmithkline Biologicals SA
- Compositions and methods for treating or preventing intestinal paracellular permeability25 Jun 2024US 12,016,889 B29 Meters Biopharma, Inc.
- Systems for modulating microbiome target cells, methods and compositions thereof16 Jul 2026US 2026/0199403 A1Trobix Bio Ltd.
- Attenuation of cytokine release syndrome in immunotherapy18 Jun 2026US 2026/0166069 A1Microcrispr Pvt Ltd.
- Targeted genome modification using circular single-stranded dna28 May 2026US 2026/0146261 A1Full Circles Therapeutics, Inc.
- Phage and Its Use in Compensating Soil Nitrogen Fixation22 Jan 2026US 2026/0022297 A1Institute of Soil Science, Chinese Academy of Sciences
- Targeting cells in stressed growing conditions1 Jan 2026US 2026/0002165 A1SNIPR Biome ApS
Most cited
By later US patents
- Methods and compositions for genomic modification109US 6,632,672 B2The Board of Trustees of the Leland Stanford Junior University · 2003
- Evolution of site-specific recombinases66US 10,392,674 B2President and Fellows of Harvard College · 2019
- Multi-chain eukaryotic display vectors and uses thereof27US 9,034,601 B2Dyax Corp. · 2015
- Multi-chain eukaryotic display vectors and uses thereof18US 9,005,927 B2Dyax Corp. · 2015
- Evolution of site-specific recombinases12US 11,104,967 B2President and Fellows of Harvard College · 2021